Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
381 hedge funds and large institutions have $7.31B invested in Shockwave Medical, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 155 increasing their positions, 126 reducing their positions, and 80 closing their positions.
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
54% more call options, than puts
Call options by funds: $57.6M | Put options by funds: $37.4M
23% more repeat investments, than reductions
Existing positions increased: 155 | Existing positions reduced: 126
10% more capital invested
Capital invested by funds: $6.64B → $7.31B (+$665M)
8% less funds holding
Funds holding: 415 → 381 (-34)
34% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 80
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$91M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$75.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$74.5M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$57.4M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$50.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$86.9M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$55.5M |
| 3 |
Millennium Management
New York
|
-$52.7M |
| 4 |
Renaissance Technologies
New York
|
-$40.2M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$40M |
SWAV Hedge Fund Activity: Q1 2023 in Review
381 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q1 2023, worth a combined $7.31B — up 10% from $6.64B a quarter earlier.
Sellers outnumbered buyers: 80 funds closed out of SWAV and 53 opened new positions — a net loss of 27 holders — while 126 trimmed existing stakes and 155 added.
The largest buyer was JP Morgan Chase, adding an estimated $91M. The largest seller was Fidelity Investments, cutting an estimated $86.9M.
- 381 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q1 2023, down from 415 in Q4 2022.
- Funds reported $7.31B of Shockwave Medical, Inc. Common Stock stock for Q1 2023, up 10% quarter-over-quarter.
- 53 funds opened new Shockwave Medical, Inc. Common Stock positions in Q1 2023 and 80 closed out, a net change of -27 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q1 2023 was JP Morgan Chase, an estimated $91M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q1 2023 was Fidelity Investments, an estimated $86.9M sold.
Based on aggregated 13F filings for Q1 2023.